Bio Essence Corporation
Bio Essence Corporation engages in the manufacturing and distributing health supplement products. It also offers original equipment manufacturing services. Bio Essence Corporation was incorporated in 2000 and is headquartered in Irvine, California.
Bio Essence Corporation (BIOE) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.060x
Based on the latest financial reports, Bio Essence Corporation (BIOE) has a cash flow conversion efficiency ratio of -0.060x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($186.97K) by net assets ($-3.10 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Bio Essence Corporation - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how Bio Essence Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Bio Essence Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bio Essence Corporation ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Guna Timur Raya PT
JK:TRUK
|
0.003x |
|
WESCO INTL
MU:WP7
|
0.060x |
|
Clal Industries and Beverages Ltd
TA:CLBV
|
-0.001x |
|
Susglobal Energy Corp
OTCQB:SNRG
|
0.013x |
|
Charan Insurance Public Company Limited
BK:CHARAN
|
0.003x |
|
MBANK (BRU.SG)
STU:BRU
|
0.166x |
|
ECM Libra Financial Group Bhd
KLSE:2143
|
0.020x |
|
4LE
F:4LE
|
-0.226x |
Annual Cash Flow Conversion Efficiency for Bio Essence Corporation (2017–2024)
The table below shows the annual cash flow conversion efficiency of Bio Essence Corporation from 2017 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-2.97 Million | $623.87K | -0.210x | -134.01% |
| 2023-12-31 | $-1.66 Million | $-1.03 Million | 0.618x | +184.48% |
| 2022-12-31 | $-3.24 Million | $-703.24K | 0.217x | -59.25% |
| 2021-12-31 | $-2.43 Million | $-1.29 Million | 0.533x | +29.52% |
| 2020-12-31 | $-1.78 Million | $-732.74K | 0.411x | -50.22% |
| 2019-12-31 | $-1.09 Million | $-896.92K | 0.826x | +116.85% |
| 2018-12-31 | $169.43K | $-831.00K | -4.905x | -256.09% |
| 2017-12-31 | $1.53 Million | $-2.10 Million | -1.377x | -- |